Medicalix Ltd

What Medicalix Ltd does

Medicalix Ltd. is an Israel-based, privately held professional services firm founded in 2012 by Avner Dor that provides end-to-end pharmacovigilance (PV), device vigilance, and medical information services to pharmaceutical, medical device, cosmetics, food supplements, and biocides companies operating in Israel. The company is the local Israeli partner of choice for global pharmacovigilance providers, supplying Local Qualified Person for Pharmacovigilance (LQPPV) and Deputy LQPPV appointments, Individual Case Safety Report (ICSR) processing, Periodic Safety Update Report (PSUR) preparation and review, signal detection, regulatory intelligence, risk management plan support, local literature search, and pharmacovigilance training. Its underlying platform is a pharmacovigilance quality management system dual-compliant with EU Good Pharmacovigilance Practice (GVP) guidelines and Israeli Ministry of Health regulations, anchored by the firm's first-mover position established when Israeli MoH Procedure 6 was enacted in 2012.

The company monetizes through customized, multi-year professional services engagements priced per scope rather than on a published rate card, with revenue generated from four service lines: Pharmacovigilance Services (QPPV appointment and full PV outsourcing), Medical Information Services (24/7 inquiry handling in Hebrew, Arabic, Russian, and English by pharmacists, physicians, and nurses), Social Networks & Digital Media Monitoring (adverse-event surveillance across Facebook, Twitter, Instagram, and TikTok in Hebrew and Arabic), and an "Extending Global Reach" partnership channel where Medicalix acts as the in-country affiliate for international PV service providers seeking Israeli coverage. Customer acquisition is primarily direct B2B field sales supplemented by website, LinkedIn, and WhatsApp inbound channels. The company is founder-controlled, operates from a single headquarters in Kochav Yair, and reports no external institutional investors, no M&A activity, no funding rounds, and no disclosed revenue or headcount.

Name

Medicalix Ltd

Legal name

Medicalix Ltd.

Website

https://medicalix.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

1–10 employees

Short description

Medicalix Ltd. is an Israel-based, privately held pharmacovigilance and medical information services firm founded in 2012, serving pharmaceutical, medical device, cosmetics, food supplements, and biocides companies in Israel, and acting as the local affiliate for global PV service providers seeking Israeli market access.

Ownership category

akta.pro rank

Product category

Pharmacovigilance Services

SIC

Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Medical Review & Pharmacovigilance Quality (PV QA/Audits/SOPs) (HLAGALAH)

akta.pro secondary industries

Medical Information Services (MI Contact Centers) (HLAGALAE), Signal Detection & Safety Analytics (Epidemiology/RWE) (HLAGALAC), Patient Support Programs & Device/Vaccine Vigilance (PSP/PSUR support) (HLAGALAK)

Keywords

• Pharmacovigilance services
• Medical information services
• Device vigilance
• Adverse event monitoring
• Regulatory compliance services

Headquarters

HQ city

En Habesor

HQ country

Israel

HQ region

Middle East

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmacovigilance Services: Professional pharmacovigilance services including QPPV appointment, ICSR processing, case handling, PSUR report writing and review, signal detection, literature search, and training services for pharmaceutical and medical device companies operating in Israel.
2. Medical Information Services: Medical information services provided by pharmacists responding to healthcare provider and patient inquiries, including proactive information distribution, adverse event identification, product quality complaint handling, and out-of-hours services.
3. Social Media Monitoring Services: Monitoring services for social media platforms and websites to identify adverse effects related to marketing campaigns, with reporting to clients and/or regulatory authorities.
4. Local Market Partnership Services: Services enabling global pharmacovigilance providers to extend their reach to Israel, including local QPPV appointments, regulatory intelligence, RMP support, and local literature searches.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Medicalix Ltd provides end-to-end pharmacovigilance, device vigilance, and medical information services to pharmaceutical, medical device, cosmetics, food supplements, biocides, and other health-related product companies operating in Israel. Services include appointment of Local Qualified Persons for Pharmacovigilance (QPPVs and LCPPVs), ICSR processing, PSUR report writing and review, signal detection, regulatory intelligence, RMP support, and PV training. The company also operates 24/7 medical information services in Hebrew, Arabic, Russian, and English, and social media/digital media monitoring for adverse effects. Medicalix partners with global pharmacovigilance providers to extend their services into the Israeli market.

Product overview

Medicalix Ltd is a pharmacovigilance and medical information service provider offering a comprehensive suite of professional services in Israel. The company provides end-to-end pharmacovigilance (PV) and device vigilance services, medical information services, social networks and digital media monitoring, and partnership services to extend global providers' reach to Israel. The core offerings include: (1) Pharmacovigilance Services featuring Local Qualified Person for Pharmacovigilance (LQPPV) appointment, ICSR processing, regulatory intelligence, RMP support, PSUR handling, PV training, literature search, signal detection, and consulting; (2) Medical Information Services with 24/7 support in Hebrew, Arabic, Russian, and English; (3) Social Networks & Digital Media Monitoring supporting Hebrew and Arabic; and (4) Extending Global Reach partnership services. Medicalix operates a quality system compliant with EU GVP guidelines and Israeli Ministry of Health regulations.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmacovigilance and Device Vigilance Services End-to-end pharmacovigilance and device vigilance services for pharmaceutical and medical device companies in Israel. Includes appointment of Local Qualified Person for Pharmacovigilance (LQPPV) and Deputy LQPPV, ICSR processing and reporting, regulatory intelligence, Risk Management Plan (RMP) support, PSUR handling, pharmacovigilance training, local literature search, signal detection, PV consulting, and inspection readiness.
• Medical Information Services Medical information services delivered by a team of pharmacists, physicians, and nurses for pharmaceutical and medical device companies. Includes medical inquiry intake and management, providing medical information to healthcare professionals and the public, identifying and reporting safety information, product quality complaint handling, proactive information distribution, and out-of-hours 24/7 service availability. Supports Hebrew, Arabic, Russian, and English.
• Social Networks and Digital Media Monitoring Monitoring of social media platforms and websites (including for marketing campaigns) to identify adverse effects and report them to clients and/or regulatory authorities. Supports Hebrew and Arabic language coverage.
• Extending Global Reach Partnership Services Partnership services enabling global pharmacovigilance and medical information service providers to extend their services into the Israeli market. Includes local QPPV appointment (Lead LQPPV and Deputy LQPPV), ICSR processing, local regulatory intelligence, RMP support, PSUR handling and submission, pharmacovigilance training, local literature search, and PV consulting on behalf of the global partner.

Named customers2 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Leading Global Pharmacovigilance Service ProviderscoreStrategic or Co-development PartnerMedicalix partners with leading global pharmacovigilance service providers to extend their services to the Israeli market. Services include local QPPV appointment (Lead LQPPV and Deputy LQPPV), Individual Case Safety Report (ICSR) processing, local regulatory intelligence, Risk Management Plan (RMP) support, Periodic Safety Update Report (PSUR) handling and submission, pharmacovigilance training, and local literature search.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Market position

Competitive moat4 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/medicalix

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medicalix Ltd